Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Paoloni · SciRah

Researcher profile · Semantic Scholar

F. Paoloni

Share profile

F. Paoloni — researcher profile on SciRah

h-index: 8
Works: 27
Citations: 248

Most-cited papers

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
D. Pinato, J. Aguilar-Company, D. Ferrante, G. Hanbury +143 more
2022The Lancet Oncology73 citations Open access
Semantic Scholar
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab
E. Lenci, L. Cantini, Federica Pecci, V. Cognigni +16 more
2021Journal of Clinical Medicine45 citations Open access
Semantic Scholar
Long-term effect of subthalamic and pallidal deep brain stimulation for status dystonicus in children with methylmalonic acidemia and GNAO1 mutation
A. Benato, M. Carecchio, A. Burlina, F. Paoloni +5 more
2019Journal of neural transmission35 citations
Semantic Scholar
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
A. Cortellini, J. Tabernero, U. Mukherjee, R. Salazar +123 more
2023The Lancet Oncology29 citations Open access
Semantic Scholar
Development of detailed finite element models for in silico analyses of brain impact dynamics
P. Pavan, M. Nasim, Veronica Brasco, S. Spadoni +6 more
2022Comput. Methods Programs Biomed.18 citations Open access
Semantic Scholar
Host-related Determinants of Response to Immunotherapy in Non-small Cell Lung Cancer: The Interplay of Body Composition, Metabolism, Sex and Immune Regulation
Valentina Santo, L. Brunetti, Federica Pecci, M. Peroni +7 more
2025Current Oncology Reports14 citations
Semantic Scholar
Unraveling the link between cholesterol and immune system in cancer: from biological mechanistic insights to clinical evidence. A narrative review.
Federica Pecci, V. Cognigni, G. C. Giudice, F. Paoloni +13 more
2025Critical reviews in oncology/hematology10 citations
Semantic Scholar
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study
L. Cantini, F. Paoloni, Federica Pecci, F. Spagnolo +47 more
2023Journal of the National Cancer Institute10 citations Open access
Semantic Scholar
Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers
A. Parisi, Francesca Rossi, Chiara De Filippis, F. Paoloni +5 more
2023OncoTargets and Therapy5 citations Open access
Semantic Scholar
Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy.
F. Perrone, Federica Pecci, M. Maffezzoli, G. C. Giudice +13 more
2024Immunotherapy2 citations
Semantic Scholar
Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC
L. Cantini, Federica Pecci, Filippo Merloni, A. Lanese +4 more
2021Exploration of Targeted Anti-tumor Therapy2 citations Open access
Semantic Scholar
Clinically interpretable nomogram combining body composition and clinicopathological features for one year survival prediction in advanced solid tumors
Giulia Bruschi, F. Paoloni, Federica Pecci, Elisabetta Tola +24 more
2026Scientific Reports1 citations Open access
Semantic Scholar
Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with oncogene-driver negative NSCLC who have never smoked.
E. Gariazzo, A. Elkrief, K. Concannon, G. Metro +15 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
Differential predictive impact of PD-L1 expression on immunotherapy outcomes and immunophenotype in squamous versus non-squamous NSCLC.
Valentina Santo, A. Elkrief, K. Concannon, A. Di Federico +11 more
2025Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Prospective nutritional status and body mass composition assessment in patients with advanced NSCLC treated with immune checkpoint inhibitors.
Federica Pecci, V. Cognigni, G. Bruschi, M. Gualtieri +16 more
2024Journal of Clinical Oncology1 citations Open access
Semantic Scholar
FP12.06 GRIm-Score Variations Predict Outcome in Metastatic NSCLC Patients Treated with First-Line Pembrolizumab
E. Lenci, L. Cantini, S. Rinaldi, Federica Pecci +16 more
20211 citations Open access
Semantic Scholar
Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study
T. El Zarif, Sarah Abou Alaiwi, A. Nassar, E. Gariazzo +48 more
2026The Oncologist0 citations Open access
Semantic Scholar
Outcomes of first-line chemo-immunotherapy in advanced non-squamous NSCLC according to KRAS status: An Italian real-world study
A. Leonetti, V. Callegari, Fabiana Perrone, G. Maglietta +44 more
2026Tumori0 citations Open access
Semantic Scholar
Pan-cancer G2C-Pro: A two-stage Gaussian clustering to prognostically stratify patients with advanced tumors treated with immune checkpoint inhibitors.
F. Paoloni, Federica Pecci, G. Bruschi, Elisabetta Tola +14 more
2024Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Feature Engineering Assessment of Tumor Infiltrating Lymphocytes in Lung Adenocarcinoma
Giulia Bruschi, Agnese Sbrollini, Federica Pecci, V. Cognigni +6 more
2024Annual International Conference of the IEEE Engineering in Medicine and Biology Society0 citations
Semantic Scholar
Elucidating the role of baseline and on-treatment nutritional status and body composition on clinical outcomes in advanced nsclc patients treated with immunotherapy
G. Mentrasti, S. Lunetti, F. Pecci, V. E. Mignini +18 more
2024Clinical Nutrition ESPEN0 citations
Semantic Scholar
85P NSCLC-Pro ClustAI: A machine learning model to prognostically stratify patients with advanced NSCLC treated with immune checkpoint inhibitors
V. Cognigni, F. Pecci, G. Bruschi, A. Sbrollini +14 more
2024ESMO Open0 citations Open access
Semantic Scholar
66P Outcome predictors for pembrolizumab alone or with chemotherapy in advanced non-small cell lung cancer (NSCLC)
L. Zullo, E. Cella, F. Paoloni, M. Gualtieri +12 more
2023Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
1456P Exploring biological and molecular factors as outcome predictors for pembrolizumab (Pem) or pembrolizumab-chemotherapy (Pem-CT) in advanced non-small cell lung cancer (NSCLC)
L. Zullo, M. Aldea, F. Paoloni, A. Rosa +16 more
2023Annals of Oncology0 citations
Semantic Scholar
EP11.01-01 Final Analysis of First-Line Chemo-Immunotherapy in Patients with Advanced Lung Adenocarcinoma: An Italian Real-World Study
A. Leonetti, F. Perrone, M. Puntoni, P. Bordi +29 more
2023Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
EP08.01-007 Real-World Outcomes of Patients with Advanced Lung Adenocarcinoma Treated with First-Line Chemo-Immunotherapy in Italy
A. Perrone, M. Puntoni, P. Bordi, G. Maglietta +21 more
2022Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
Extended interval dosing in patients with cancer receiving immune checkpoint inhibitors: Safety analysis from the EDICI study.
L. Cantini, F. Paoloni, Federica Pecci, F. Spagnolo +16 more
2022Journal of Clinical Oncology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Federica Pecci×16
Invite
Federica Pecci — researcher profile on SciRah
V. Cognigni×10
Invite
V. Cognigni — researcher profile on SciRah
L. Cantini×8
Invite
L. Cantini — researcher profile on SciRah
G. Mentrasti×7
Invite
G. Mentrasti — researcher profile on SciRah

×6

Invite

L. Cantini — researcher profile on SciRah

M. Gualtieri×6

Invite

M. Gualtieri — researcher profile on SciRah

A. Cortellini×5

Invite

A. Cortellini — researcher profile on SciRah

C. Ficorella×5

Invite

C. Ficorella — researcher profile on SciRah

Invite

R. Berardi — researcher profile on SciRah

Invite

A. Guida — researcher profile on SciRah

V. Agostinelli×5

Invite

V. Agostinelli — researcher profile on SciRah

Invite

J. Aerts — researcher profile on SciRah